Systematic screening studies, performed mainly in patients with diabetes mellitus, have revealed an unexpectedly high prevalence of occult Cushing syndrome. However, a screening strategy is only justified if it is supported by enough evidence of its efficacy and if benefits will outweigh drawbacks. The authors review currently available systematic screening studies for occult Cushing syndrome and assess the indications for and against screening for this condition.
- Antoine Tabarin
- Paul Perez
